Click for best price
Opioid Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 9479 million
|
Forecast Market size by 2030 |
US$ 14130 million
|
| Growth Rate |
CAGR of 5.8% |
Number of Pages |
84 Pages |
This research report provides a comprehensive analysis of the Opioid Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Opioid Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Opioid Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Opioid Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Opioid Drugs market presents opportunities for various stakeholders, including Anesthesia, Pain relief. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Opioid Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Opioid Drugs market was valued at US$ 9479 million in 2023 and is projected to reach US$ 14130 million by 2030, at a CAGR of 5.8% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Opioid Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Opioid Drugs market.
Market Overview: The report provides a comprehensive overview of the Opioid Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Buprenorphine, Fentanyl), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Opioid Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Opioid Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Opioid Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Opioid Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Opioid Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Opioid Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Opioid Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Opioid Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Opioid Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others
Market segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others
Global Opioid Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson?Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opioid Drugs, market overview.
Chapter 2: Global Opioid Drugs market size in revenue.
Chapter 3: Detailed analysis of Opioid Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioid Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Opioid Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 9479 million
|
| Forecast Market size by 2030 |
US$ 14130 million
|
| Growth Rate |
CAGR of 5.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
84 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Opioid Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Drugs Overall Market Size
2.1 Global Opioid Drugs Market Size: 2023 VS 2030
2.2 Global Opioid Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Opioid Drugs Players in Global Market
3.2 Top Global Opioid Drugs Companies Ranked by Revenue
3.3 Global Opioid Drugs Revenue by Companies
3.4 Top 3 and Top 5 Opioid Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Opioid Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid Drugs Players in Global Market
3.6.1 List of Global Tier 1 Opioid Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Opioid Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid Drugs Market Size Markets, 2023 & 2030
4.1.2 Buprenorphine
4.1.3 Fentanyl
4.1.4 Hydrocodone
4.1.5 Morphine
4.1.6 Oxycodone
4.1.7 Tramadol
4.1.8 Others
4.2 By Type - Global Opioid Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioid Drugs Revenue, 2019-2024
4.2.2 By Type - Global Opioid Drugs Revenue, 2025-2030
4.2.3 By Type - Global Opioid Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioid Drugs Market Size, 2023 & 2030
5.1.2 Anesthesia
5.1.3 Pain relief
5.1.4 Cough suppression
5.1.5 Diarrhea suppression
5.1.6 Deaddiction
5.1.7 Others
5.2 By Application - Global Opioid Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioid Drugs Revenue, 2019-2024
5.2.2 By Application - Global Opioid Drugs Revenue, 2025-2030
5.2.3 By Application - Global Opioid Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Opioid Drugs Market Size, 2023 & 2030
6.2 By Region - Global Opioid Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioid Drugs Revenue, 2019-2024
6.2.2 By Region - Global Opioid Drugs Revenue, 2025-2030
6.2.3 By Region - Global Opioid Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Opioid Drugs Revenue, 2019-2030
6.3.2 US Opioid Drugs Market Size, 2019-2030
6.3.3 Canada Opioid Drugs Market Size, 2019-2030
6.3.4 Mexico Opioid Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Opioid Drugs Revenue, 2019-2030
6.4.2 Germany Opioid Drugs Market Size, 2019-2030
6.4.3 France Opioid Drugs Market Size, 2019-2030
6.4.4 U.K. Opioid Drugs Market Size, 2019-2030
6.4.5 Italy Opioid Drugs Market Size, 2019-2030
6.4.6 Russia Opioid Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Opioid Drugs Market Size, 2019-2030
6.4.8 Benelux Opioid Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Opioid Drugs Revenue, 2019-2030
6.5.2 China Opioid Drugs Market Size, 2019-2030
6.5.3 Japan Opioid Drugs Market Size, 2019-2030
6.5.4 South Korea Opioid Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Opioid Drugs Market Size, 2019-2030
6.5.6 India Opioid Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Opioid Drugs Revenue, 2019-2030
6.6.2 Brazil Opioid Drugs Market Size, 2019-2030
6.6.3 Argentina Opioid Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Opioid Drugs Revenue, 2019-2030
6.7.2 Turkey Opioid Drugs Market Size, 2019-2030
6.7.3 Israel Opioid Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Opioid Drugs Market Size, 2019-2030
6.7.5 UAE Opioid Drugs Market Size, 2019-2030
7 Opioid Drugs Companies Profiles
7.1 Acura Pharmaceuticals
7.1.1 Acura Pharmaceuticals Company Summary
7.1.2 Acura Pharmaceuticals Business Overview
7.1.3 Acura Pharmaceuticals Opioid Drugs Major Product Offerings
7.1.4 Acura Pharmaceuticals Opioid Drugs Revenue in Global Market (2019-2024)
7.1.5 Acura Pharmaceuticals Key News & Latest Developments
7.2 Cipher Pharmaceutical Inc.
7.2.1 Cipher Pharmaceutical Inc. Company Summary
7.2.2 Cipher Pharmaceutical Inc. Business Overview
7.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Major Product Offerings
7.2.4 Cipher Pharmaceutical Inc. Opioid Drugs Revenue in Global Market (2019-2024)
7.2.5 Cipher Pharmaceutical Inc. Key News & Latest Developments
7.3 Daiichi Sankyo
7.3.1 Daiichi Sankyo Company Summary
7.3.2 Daiichi Sankyo Business Overview
7.3.3 Daiichi Sankyo Opioid Drugs Major Product Offerings
7.3.4 Daiichi Sankyo Opioid Drugs Revenue in Global Market (2019-2024)
7.3.5 Daiichi Sankyo Key News & Latest Developments
7.4 Johnson?Johnson
7.4.1 Johnson?Johnson Company Summary
7.4.2 Johnson?Johnson Business Overview
7.4.3 Johnson?Johnson Opioid Drugs Major Product Offerings
7.4.4 Johnson?Johnson Opioid Drugs Revenue in Global Market (2019-2024)
7.4.5 Johnson?Johnson Key News & Latest Developments
7.5 Lupin Limited
7.5.1 Lupin Limited Company Summary
7.5.2 Lupin Limited Business Overview
7.5.3 Lupin Limited Opioid Drugs Major Product Offerings
7.5.4 Lupin Limited Opioid Drugs Revenue in Global Market (2019-2024)
7.5.5 Lupin Limited Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Opioid Drugs Major Product Offerings
7.6.4 Pfizer Opioid Drugs Revenue in Global Market (2019-2024)
7.6.5 Pfizer Key News & Latest Developments
7.7 Sun Pharmaceuticals
7.7.1 Sun Pharmaceuticals Company Summary
7.7.2 Sun Pharmaceuticals Business Overview
7.7.3 Sun Pharmaceuticals Opioid Drugs Major Product Offerings
7.7.4 Sun Pharmaceuticals Opioid Drugs Revenue in Global Market (2019-2024)
7.7.5 Sun Pharmaceuticals Key News & Latest Developments
7.8 Teva Pharmaceutical Industries Ltd.
7.8.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Ltd. Opioid Drugs Revenue in Global Market (2019-2024)
7.8.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Opioid Drugs Market Opportunities & Trends in Global Market
Table 2. Opioid Drugs Market Drivers in Global Market
Table 3. Opioid Drugs Market Restraints in Global Market
Table 4. Key Players of Opioid Drugs in Global Market
Table 5. Top Opioid Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Opioid Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Opioid Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Opioid Drugs Product Type
Table 9. List of Global Tier 1 Opioid Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Opioid Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Opioid Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Opioid Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Opioid Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Opioid Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Opioid Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Opioid Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Opioid Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Opioid Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Opioid Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Opioid Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Opioid Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Opioid Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Opioid Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Opioid Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Opioid Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Opioid Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Opioid Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Opioid Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Acura Pharmaceuticals Company Summary
Table 31. Acura Pharmaceuticals Opioid Drugs Product Offerings
Table 32. Acura Pharmaceuticals Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Acura Pharmaceuticals Key News & Latest Developments
Table 34. Cipher Pharmaceutical Inc. Company Summary
Table 35. Cipher Pharmaceutical Inc. Opioid Drugs Product Offerings
Table 36. Cipher Pharmaceutical Inc. Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Cipher Pharmaceutical Inc. Key News & Latest Developments
Table 38. Daiichi Sankyo Company Summary
Table 39. Daiichi Sankyo Opioid Drugs Product Offerings
Table 40. Daiichi Sankyo Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Daiichi Sankyo Key News & Latest Developments
Table 42. Johnson?Johnson Company Summary
Table 43. Johnson?Johnson Opioid Drugs Product Offerings
Table 44. Johnson?Johnson Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Johnson?Johnson Key News & Latest Developments
Table 46. Lupin Limited Company Summary
Table 47. Lupin Limited Opioid Drugs Product Offerings
Table 48. Lupin Limited Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Lupin Limited Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Opioid Drugs Product Offerings
Table 52. Pfizer Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Pfizer Key News & Latest Developments
Table 54. Sun Pharmaceuticals Company Summary
Table 55. Sun Pharmaceuticals Opioid Drugs Product Offerings
Table 56. Sun Pharmaceuticals Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Sun Pharmaceuticals Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Ltd. Company Summary
Table 59. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Offerings
Table 60. Teva Pharmaceutical Industries Ltd. Opioid Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
List of Figures
Figure 1. Opioid Drugs Segment by Type in 2023
Figure 2. Opioid Drugs Segment by Application in 2023
Figure 3. Global Opioid Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Opioid Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Opioid Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opioid Drugs Revenue in 2023
Figure 8. By Type - Global Opioid Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Opioid Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Opioid Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Opioid Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Opioid Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Opioid Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Opioid Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Opioid Drugs Revenue Market Share, 2019-2030
Figure 16. US Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Opioid Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Opioid Drugs Revenue Market Share, 2019-2030
Figure 28. China Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Opioid Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Opioid Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Opioid Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Acura Pharmaceuticals Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Cipher Pharmaceutical Inc. Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Daiichi Sankyo Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Johnson?Johnson Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Lupin Limited Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Pfizer Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Sun Pharmaceuticals Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Teva Pharmaceutical Industries Ltd. Opioid Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
